TYRP1 and melanoma: Furthermore, in a syngeneic mouse myeloma model, in vivo programmed anti-gp75 monocytes inhibited the growth of B16/F10-OVA melanoma tumors and created an inflammatory TME that enhanced the function of cytotoxic T cells and antigen presentation capacity of dendritic cells.